Dapagliflozin is a medication used to treat type 2 diabetes. However, during the manufacturing process, impurities may be introduced which can affect the purity and potency of the drug. These impurities can be harmful to human health and therefore their identification and control are critical for ensuring the safety and efficacy of dapagliflozin. Analytical techniques such as HPLC, LC-MS, and NMR are used for the detection and quantification of these impurities